Pfizer plans to seek FDA nod for COVID-19 shot in kids 5 to 11 after positive datanews2021-09-20T15:23:41+00:00September 20th, 2021|Fierce Pharma|
Back to consumer: Novartis’ digital chief Betrand Bodson is leaving pharma after helping break groundnews2021-09-20T14:31:22+00:00September 20th, 2021|Fierce Pharma|
Former Mylan executive pleads guilty to insider trading that netted him $4.27Mnews2021-09-20T14:20:09+00:00September 20th, 2021|Fierce Pharma|
Biogen beefs up in biosimilars—again—with FDA nod for copycat to Roche’s blockbuster Lucentisnews2021-09-20T13:44:26+00:00September 20th, 2021|Fierce Pharma|
Biogen beefs up in biosimilars—again—with FDA nod for Samsung-partnered Lucentis copycatnews2021-09-20T13:44:26+00:00September 20th, 2021|Fierce Pharma|
ESMO: Bristol Myers’ Opdivo-Yervoy, Pfizer-Merck KGaA’s Bavencio hit walls in head and neck cancernews2021-09-19T15:14:43+00:00September 19th, 2021|Fierce Pharma|
Novartis, determined to dethrone Pfizer, will launch bold Kisqali-Ibrance head-to-head trial in breast cancernews2021-09-19T14:16:17+00:00September 19th, 2021|Fierce Pharma|
Sanofi’s ‘Flu Shot Friday’ campaign teams up with celebrity actress and nurses’ groupnews2021-09-18T17:03:24+00:00September 18th, 2021|Fierce Pharma|
ESMO: In newly diagnosed stomach cancer, 2 Opdivo-Yervoy flops show immunotherapy alone might not be the answernews2021-09-18T16:45:12+00:00September 18th, 2021|Fierce Pharma|
ESMO: Regeneron, Sanofi take another stab at lung cancer with Libtayo-chemo win. Should Merck worry?news2021-09-18T13:49:20+00:00September 18th, 2021|Fierce Pharma|
